Community-level social capital and polypharmacy among public assistance recipients in Japan: A multilevel cross-sectional study

Masayuki Kasahara¹, Haruna Kawachi², Keiko Ueno³, Shiho Kino⁴, Naoki Kondo³, Shunya Ikeda¹, Daisuke Nishioka^{2

5}

Affiliations

¹ Department of Medical and Biopharmaceutical Sciences, Graduate School of Pharmacy, International University of Health and Welfare, 4-1-26 Akasaka, Minato-ku, Tokyo, Japan.
² Department of Medical Statistics, Medical Research & Development Center, Osaka Medical and Pharmaceutical University, Daigakumachi 2-7, Takatsuki-shi, Osaka, Japan.
³ Department of Social Epidemiology, Graduate School of Medicine and School of Public Health, Kyoto University, Floor 2, Science Frontier Laboratory, Yoshida-konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto, Japan.
⁴ Department of Preventive Oral Health Care Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
⁵ Department of Social Impact Assessment, Graduate School of Medicine and School of Public Health, Kyoto University, Floor 2, Science Frontier Laboratory, Yoshida-Konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto, Japan.

PMID: 40212734
PMCID: PMC11984595
DOI: 10.1016/j.ssmph.2025.101788

Community-level social capital and polypharmacy among public assistance recipients in Japan: A multilevel cross-sectional study

Masayuki Kasahara et al. SSM Popul Health. 2025.

. 2025 Mar 20:30:101788.

doi: 10.1016/j.ssmph.2025.101788. eCollection 2025 Jun.

Authors

Masayuki Kasahara¹, Haruna Kawachi², Keiko Ueno³, Shiho Kino⁴, Naoki Kondo³, Shunya Ikeda¹, Daisuke Nishioka^{2

5}

Affiliations

¹ Department of Medical and Biopharmaceutical Sciences, Graduate School of Pharmacy, International University of Health and Welfare, 4-1-26 Akasaka, Minato-ku, Tokyo, Japan.
² Department of Medical Statistics, Medical Research & Development Center, Osaka Medical and Pharmaceutical University, Daigakumachi 2-7, Takatsuki-shi, Osaka, Japan.
³ Department of Social Epidemiology, Graduate School of Medicine and School of Public Health, Kyoto University, Floor 2, Science Frontier Laboratory, Yoshida-konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto, Japan.
⁴ Department of Preventive Oral Health Care Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
⁵ Department of Social Impact Assessment, Graduate School of Medicine and School of Public Health, Kyoto University, Floor 2, Science Frontier Laboratory, Yoshida-Konoe-cho, Sakyo-ku, Kyoto-shi, Kyoto, Japan.

PMID: 40212734
PMCID: PMC11984595
DOI: 10.1016/j.ssmph.2025.101788

Abstract

•Polypharmacy is common among low socioeconomic public assistance recipients.•69.5 % of adults on public assistance had polypharmacy with ≥6 oral medications.•Higher civic participation was associated with lower excessive polypharmacy prevalence.•Higher social cohesion was associated with higher excessive polypharmacy prevalence.•Polypharmacy should be addressed based on civic participation and social cohesion.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest statement associated with this research.

Figures

**Fig. 1**
Participants flow for the analytic sample.

See this image and copyright information in PMC

Cited by

Working-age patients with medically unexplained oral symptoms who receive public assistance in Japan.
Suga T, Toyofuku A. Suga T, et al. Sci Rep. 2025 Aug 2;15(1):28218. doi: 10.1038/s41598-025-14427-9. Sci Rep. 2025. PMID: 40753111 Free PMC article.

References

1. Amemiya A., Saito J., Saito M., Takagi D., Haseda M., Tani Y., et al. Social capital and the improvement in functional ability among older people in Japan: A multilevel survival analysis using JAGES data. International Journal of Environmental Research and Public Health. 2019;16(8):1310. doi: 10.3390/ijerph16081310. - DOI - PMC - PubMed
1. Arabyat R.M., Alazzam O.M., Al-Azzam S.I., Nusair M.B. Association between Charlson comorbidity index and polypharmacy: A retrospective database study from Jordan. International Journal of Pharmacy Practice. 2021;29(6):580–586. doi: 10.1093/ijpp/riab067. - DOI - PubMed
1. Berkman L.F., Glass T., Brissette I., Seeman T.E. From social integration to health: Durkheim in the new millennium. Social Science & Medicine. 2000;51(6):843–857. doi: 10.1016/s0277-9536(00)00065-4. - DOI - PubMed
1. Berkman L.F., Kawachi I., Maria Glymour M. Oxford University Press; 2014. Social epidemiology.https://play.google.com/store/books/details?id=qHpYCwAAQBAJ
1. Bjerrum L., Rosholm J.U., Hallas J., Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharmacology. 1997;53(1):7–11. doi: 10.1007/s002280050329. - DOI - PubMed

LinkOut - more resources

Full Text Sources
- Elsevier Science
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Community-level social capital and polypharmacy among public assistance recipients in Japan: A multilevel cross-sectional study

Affiliations

Community-level social capital and polypharmacy among public assistance recipients in Japan: A multilevel cross-sectional study

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources